Identification | Back Directory | [Name]
Farglitazar | [CAS]
196808-45-4 | [Synonyms]
G1 262570 GI 262570 GI 262570X Farglitazar N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine L-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]- 2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid (S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid | [Molecular Formula]
C34H30N2O5 | [MDL Number]
MFCD07364057 | [MOL File]
196808-45-4.mol | [Molecular Weight]
546.61 |
Hazard Information | Back Directory | [Uses]
Farglitazar is a peroxisome proliferator-activated receptor (PPAR) agonist and has been explored for treating hepatic fibrosis and type 2 diabetes. | [Uses]
Treatment of Type II diabetes (insulin action enhancer). |
|
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Website: |
http://www.energy-chemical.com |
|